Syngene International Ltd. Fundamental & Technical Research, Share Price Today

NSE : SYNGENE
NIFTY : Nifty 500
NIFTY SECTOR : Nifty Healthcare Index

About Company

Syngene International Limited, incorporated in 1993, is an internationally reputed contract research and manufacturing organization, which supports R&D programs from lead generation to clinical supplies. The company’s multi-disciplinary skills in integrated drug discovery and development include capabilities in medicinal chemistry, biology, in vivo pharmacology, toxicology, custom synthesis, process R&D, cGMP manufacturing, formulation and analytical development along with Clinical development services. The company has state-of-the-art research facilities certified with ISO 9001:2008, ISO 14001:2004, and OHSAS 18001:2007. The company’s animal facilities are GLP certified by the Indian authorities and AAALAC accredited.

Market Cap. ₹25,303 Cr.

52 Week - High/Low ₹961/608

P/E Ratio 53.99

P/B Ratio 6.04

Enterprise Value ₹25,243 Cr.

ROE % 12.07

RSI Value 34.52

EMA 50 705.65

EMA 200 765.29

Net Profit 466 Cr.

Net Profit 3year growth 15.56 Cr.

Net Profit 3 year (back) 404 Cr.

Debt to Equity 0.03 %

EPS Growth TTM 0.26 %

Current Ratio 1.69 %

100 Day SMA 759 Rs.

200 Day SMA 809 Rs.

21 Day SMA 695 Rs.

50 Day SMA 693 Rs.

Book Value 104 Rs.

EV/EBITDA Ratio 25

QoQ EPS Growth 27 %

QoQ Operating Profit Growth 22 %

QoQ Sales Growth 7 %

Sales Latest Quarter 877 Cr.

YoY Sales Growth 11 %

Market Cap. ₹25,303 Cr.

52 Week - High/Low ₹961/608

P/E Ratio 50.93

P/B Ratio 5.94

Enterprise Value ₹25,423 Cr.

ROE % 13.18

RSI Value 34.52

EMA 50 705.65

EMA 200 765.29

Net Profit 510 Cr.

Net Profit 3year growth -0.91 Cr.

Net Profit 3 year (back) 405 Cr.

Debt to Equity 0.03 %

EPS Growth TTM -2.75 %

Current Ratio 1.71 %

100 Day SMA 759 Rs.

200 Day SMA 809 Rs.

21 Day SMA 695 Rs.

50 Day SMA 693 Rs.

Book Value 106 Rs.

EV/EBITDA Ratio 22

QoQ EPS Growth 24 %

QoQ Operating Profit Growth 17 %

QoQ Sales Growth 6 %

Sales Latest Quarter 944 Cr.

YoY Sales Growth 11 %

Add Parameters

Valuation

Peer Comparison

Industry - Business Support

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages